OFEV® (nintedanib) time to face IPF head on Expanding horizons with the differentiated value of OFEV Document ID: PC-ZA-102097 05/05/2023 Author: Boehringer Ingelheim Reduced risk of Exacerbations and improved quality of Life RELATED CONTENT PC-ZA-102097 Production date: June 2023
